Portolan Capital Management, LLC Harvard Bioscience Inc Transaction History

Portolan Capital Management, LLC

$1.26 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.77 - $4.63 $1.9 Million - $3.18 Million	-685,840 Reduced 98.28%	12,000 $34,000
Q1 2024 May 15, 2024	BUY	$4.02 - $5.39 $103,193 - $138,361	25,670 Added 3.82%	697,840 $2.96 Million
Q4 2023 Feb 14, 2024	BUY	$4.0 - $5.49 $885,092 - $1.21 Million	221,273 Added 49.07%	672,170 $3.6 Million
Q3 2023 Nov 14, 2023	SELL	$4.0 - $5.82 $1.33 Million - $1.94 Million	-332,694 Reduced 42.46%	450,897 $1.94 Million
Q2 2023 Aug 14, 2023	SELL	$4.19 - $6.16 $1.09 Million - $1.6 Million	-259,955 Reduced 24.91%	783,591 $4.3 Million
Q1 2023 May 15, 2023	SELL	$2.45 - $4.22 $26,347 - $45,381	-10,754 Reduced 1.02%	1,043,546 $4.38 Million
Q4 2022 Feb 13, 2023	SELL	$2.12 - $2.86 $610,116 - $823,082	-287,791 Reduced 21.44%	1,054,300 $2.92 Million
Q3 2022 Nov 14, 2022	SELL	$2.33 - $3.92 $2.59 Million - $4.35 Million	-1,109,770 Reduced 45.26%	1,342,091 $3.44 Million
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.42 $245,763 - $481,037	-74,928 Reduced 2.97%	2,451,861 $8.83 Million
Q1 2022 May 16, 2022	SELL	$5.16 - $7.14 $61,971 - $85,751	-12,010 Reduced 0.47%	2,526,789 $15.7 Million
Q4 2021 Feb 14, 2022	BUY	$6.37 - $8.18 $1.15 Million - $1.48 Million	180,789 Added 7.67%	2,538,799 $17.9 Million
Q3 2021 Nov 15, 2021	BUY	$6.98 - $8.47 $3.77 Million - $4.57 Million	540,133 Added 29.71%	2,358,010 $16.5 Million
Q2 2021 Aug 16, 2021	BUY	$5.44 - $8.4 $1.13 Million - $1.74 Million	207,064 Added 12.85%	1,817,877 $15.1 Million
Q1 2021 May 17, 2021	BUY	$3.91 - $6.99 $1.06 Million - $1.9 Million	271,631 Added 20.28%	1,610,813 $8.8 Million
Q4 2020 Feb 16, 2021	BUY	$3.0 - $4.5 $1.08 Million - $1.62 Million	360,115 Added 36.78%	1,339,182 $5.75 Million
Q3 2020 Nov 16, 2020	BUY	$2.75 - $4.2 $1.1 Million - $1.68 Million	399,773 Added 69.01%	979,067 $2.95 Million
Q2 2020 Aug 14, 2020	BUY	$2.12 - $3.14 $1.23 Million - $1.82 Million	579,294 New	579,294 $1.8 Million

Others Institutions Holding HBIO

# of Institutions

Shares Held

30.6M

Call Options Held

700

Put Options Held

2.1K

Black Rock Inc. New York, NY

2.84M
Shares

$6.09 Million
0.0% of portfolio
Punch & Associates Investment Management, Inc. Edina, MN

2.77M
Shares

$5.93 Million
0.44% of portfolio
Harvey Partners, LLC Tarrytown, NY

2.72M
Shares

$5.81 Million
0.87% of portfolio
Amh Equity LTD

2.39M
Shares

$5.11 Million
8.88% of portfolio
Vanguard Group Inc Valley Forge, PA

2.15M
Shares

$4.61 Million
0.0% of portfolio

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.

Account